Emma Goldberg, a New York Times writer, dives into the controversial rise of ivermectin as a supposed COVID-19 cure. She discusses how this drug, originally for livestock, gained popularity despite medical warnings. The conversation reveals the public's desperate search for alternatives and the political undercurrents influencing treatment choices. Goldberg also highlights the misinformation surrounding ivermectin, the health risks of misuse, and the erosion of trust in public health guidance, reflecting the complex dynamics of the pandemic.
